The Division of Nuclear Medicine at Brown/Lifespan performs a full range of diagnostic and therapeutic Nuclear Medicine procedures including use of all currently available radiopharmaceuticals. All diagnostic Nuclear Medicine procedures from both Rhode Island Hospital and the Miriam Hospital are interpreted at Rhode Island Hospital and therapy procedures are performed at both institutions.
The division includes an extremely busy PET/CT service which provides a full range of oncologic PET/CT but also does a substantial number of both neurologic and cardiac PET/CT studies. Nuclear Cardiology studies (both SPECT and PET) are a shared service of the Division of Nuclear Medicine and the Division of Cardiology and the faculty in these divisions have a cooperative relationship to maximize trainee education and patient care.
General diagnostic Nuclear Medicine studies including planar and SPECT/CT are performed with all FDA approved radiotracers and there are four SPECT/CT cameras between Rhode Island Hospital and the Miriam Hospital.
The division provides a full range of therapeutic Nuclear Medicine services and is actively involved in the care of these patients in conjunction with the oncology services at Lifespan. Faculty members also participate actively in a variety of multidisciplinary tumor boards including regular attendance at thoracic and endocrine tumor boards.
Members of the division have been involved in a variety of research related to Nuclear Medicine. Recent research topics include the use of new oncologic therapeutic radiopharmaceuticals, new brain PET agents used for refinement of the diagnosis of cognitive decline, and the scintigraphic management of patients with suspected infection. One of our faculty members is currently the head of the Nuclear Medicine Commission at the American College of Radiology and is the leader of Nuclear Medicine education at the ACR education center and all faculty members have been actively involved in a variety of national societies related to Nuclear Medicine.